Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy

Recruiting N/A Interventional Study
Nephrectomy Nephroureterectomy Hemodynamic Management Acute Kidney Injury Chronic Kidney Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
1,724 (estimated)
Sponsor
Peking University First Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Radical nephrectomy and nephroureterectomy are common operations for the treatment of renal cell carcinoma and upper tract urothelial carcinoma, respectively. However, acute kidney injury frequently occurs after surgery. And the occurrence of acute kidney injury is associated with an increased risk of chronic kidney disease. Intraoperative hypotension is identified as an important risk factor of p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: 1. Age of 18 years or older; 2. Scheduled to undergo unilateral radical nephrectomy for renal cancer or unilateral radical nephroureterectomy for upper tract urothelial carcinoma. Exclusion criteria 1. Diagnosed with chronic kidney disease stage 4 or stage 5 (GFR\<30 ml/min/1.…
Contacts

Dong-Xin Wang, MD,PhD

86 10 83572784

wangdongxin@hotmail.com

CONTACT

Qiongfang Wu, MD

86 83575138

wuqf91@163.com

CONTACT